Literature DB >> 463920

Renal outcomes of gout and hyperuricemia.

W J Fessel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 463920     DOI: 10.1016/0002-9343(79)90076-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  32 in total

1.  Acute uric acid nephropathy in two gouty patients with moderate hyperuricemia and high urine acidity.

Authors:  B Hess; U Binswanger
Journal:  Klin Wochenschr       Date:  1990-09-03

2.  The relationship between serum uric acid and chronic kidney disease among Appalachian adults.

Authors:  Loretta Cain; Anoop Shankar; Alan M Ducatman; Kyle Steenland
Journal:  Nephrol Dial Transplant       Date:  2010-05-25       Impact factor: 5.992

3.  Asymptomatic hyperuricaemia.

Authors:  J T Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-18

4.  Hyperuricemia and gout.

Authors:  B Lo
Journal:  West J Med       Date:  1985-01

5.  Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.

Authors: 
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 6.  Gout.

Authors:  J T Scott
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 7.  Long-term management of gout and hyperuricaemia.

Authors:  J T Scott
Journal:  Br Med J       Date:  1980-11-01

8.  The risks of asymptomatic hyperuricaemia and the use of uricosuric diuretics.

Authors:  M W Johnson; W E Mitch
Journal:  Drugs       Date:  1981-03       Impact factor: 9.546

9.  Autosomal dominant transmission of gouty arthritis with renal disease in a large Japanese family.

Authors:  N Yokota; H Yamanaka; Y Yamamoto; S Fujimoto; T Eto; K Tanaka
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

Review 10.  Gout, uric acid and purine metabolism in paediatric nephrology.

Authors:  J S Cameron; F Moro; H A Simmonds
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.